Positive urine cytology but negative white-light cystoscopy: An indication for fluorescence cystoscopy?

BJU International

Volumn 103, Issue 4, 2009, Pages 484-487

  Karl, Alexander ^a   Tritschler, Stefan ^a   Stanislaus, Peter ^a   Gratzke, Christian ^a   Tilki, Derya ^a   Strittmatter, Frank ^a   Knüchel, Ruth ^b   Stief, Christian G ^a   Zaak, Dirk ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Bladder cancer; Cytology; Detection; Fluorescence cystoscopy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; BLADDER DISEASE; BLADDER DYSPLASIA; CANCER DIAGNOSIS; CANCER LOCALIZATION; CARCINOMA IN SITU; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DYSPLASIA; FEMALE; FLUORESCENCE CYSTOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; URINE CYTOLOGY; WHITE LIGHT ENDOSCOPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CYSTOSCOPY; FEMALE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINE; YOUNG ADULT;

EID: 59249094087     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08032.x     Document Type: Article

References (25)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003 53 : 5 26
2. Margel D, Tal R, Golan S, Kedar D, Engelstein D, Baniel J. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guerin immunotherapy. Urology 2007 69 : 78 82
3. van der Meijden AP, Sylvester R, Oosterlinck W et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 2005 48 : 363 71
4. Jocham D, Witjes F, Wagner S et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005 174 : 862 6
5. Daniltchenko DI, Riedl CR, Sachs MD et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 2005 174 : 2129 33
6. Jocham D, Stepp H, Waidelich R. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 2008 53 : 1138 48
7. Denzinger S, Burger M, Walter B et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007 69 : 675 9
8. Zaak D, Karl A, Knuchel R et al. Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy. BJU Int 2005 96 : 217 22
9. D'Hallewin MA, Bezdetnaya L, Guillemin F. Fluorescence detection of bladder cancer: a review. Eur Urol 2002 42 : 417 25
10. Kriegmair M, Zaak D, Stepp H et al. Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy. Eur Urol 1999 36 : 386 92
11. Loidl W, Schmidbauer J, Susani M, Marberger M. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 2005 47 : 323 6
12. Witjes JA, Moonen PM, van der Heijden AG. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study. Eur Urol 2005 47 : 319 22
13. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 48
14. Tyrkus M, Powell I, Fakr W. Cytogenetic studies of carcinoma in situ of the bladder: prognostic implications. J Urol 1992 148 : 44 6
15. Grossman HB. Improving the management of bladder cancer with fluorescence cystoscopy. J Environ Pathol Toxicol Oncol 2007 26 : 143 7
16. Fradet Y, Grossman HB, Gomella L et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007 178 : 68 73
17. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996 155 : 105 9
18. Grossman HB, Gomella L, Fradet Y et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol 2007 178 : 62 7
19. Jichlinski P, Guillou L, Karlsen SJ et al. Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer - a multicenter study. J Urol 2003 170 : 226 9
20. Burger M, Zaak D, Stief CG et al. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis. Eur Urol 2007 52 : 142 7
21. May F, Treiber U, Hartung R, Schwaibold H. Significance of random bladder biopsies in superficial bladder cancer. Eur Urol 2003 44 : 47 50
22. van der Meijden A, Oosterlinck W, Brausi M, Kurth KH, Sylvester R, de Balincourt C. Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol 1999 35 : 267 71
23. Swinn MJ, Walker MM, Harbin LJ et al. Biopsy of the red patch at cystoscopy: is it worthwhile? Eur Urol 2004 45 : 471 4
24. Sauter G, Algaba F, Amin M et al. Tumours of the urinary system: non-invasive urothelial neoplasias. In Eble JN, Sauter G, Epstein JL, Sesterhenn I, WHO Classification of Tumors of the Urinary System and Male Genital Organs. Lyon : IARCC Press, 2004 : 29 34
25. Garbar C, Mascaux C, Wespes E. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses. Cytopathology 2007 18 : 79 83